Tredu. Expert Education. Smarter Trading.

Mastering Equity and Stock Trading, Cryptocurrency Investment, Digital Assets and Global Forex Market Analysis: The Ultimate Masterclass at Tredu

Gain access to expert-led courses, live market analysis, and educational webinars that turn complex concepts into actionable strategies.Learn how to trade smarter and join our community of successful traders, building sustained financial growth.

Financial News

Maintain market dominance with real-time updates and expert analysis.
Our educators provide focused coverage across stock trading, forex markets, and crypto investing. We translate the latest financial news into practical knowledge, empowering you to trade smarter and achieve superior execution.

Proprietary Trading Strategies and
Quantitative Analysis

Sharpen your execution skills and gain a decisive edge with in-depth insights delivered by our top trading educators. Explore proven trading strategies, anticipate current market trends, and leverage expert analysis specifically designed to support your trading education and accelerate your path to sustained market success.

Tredu Team | Insights

ImmunityBio, Inc. (NASDAQ:IBRX) Targets Innovative Cancer Treatments

ImmunityBio, Inc. (NASDAQ:IBRX) Targets Innovative Cancer Treatments

H.C. Wainwright sets a price target of $15 for NASDAQ:IBRX, indicating a potential upside of 54.56%. Anktiva, ImmunityBio's flagship product, reported a 700% sales increase in 2025 and a 20% quarter-over-quarter growth. The company's market capitalization stands at approximately $9.57 billion, with a significant trading volume and stock price surge in 2026. ImmunityBio, Inc. (NASDAQ:IBRX) is a biotechnology company focused on developing innovative immunotherapy treatments. Its flagship product, Anktiva, plays a crucial role in the company's growth, particularly in treating cancers unresponsive to traditional therapies. The company competes in a dynamic market with other biotech firms striving to advance cancer treatment options. On February 23, 2026, H.C. Wainwright set a price target of $15 for IBRX, suggesting a potential upside of 54.56% from its current price of $9.71. This optimistic outlook aligns with the company's recent performance, as highlighted by a 16% surge in stock price following its fourth-quarter earnings announcement. The stock is currently priced at $9.72, reflecting an 11.67% increase, or $1.02 rise. ImmunityBio's success is largely driven by Anktiva, which saw a remarkable 700% sales increase in 2025 and a 20% quarter-over-quarter growth in the fourth quarter. Despite a negative earnings per share of $0.06, the company has shown profitability improvement for three consecutive quarters. This progress has contributed to the stock quintupling in 2026, as highlighted by the company's positive developments. The Cancer BioShield platform and Anktiva biologic product are key to ImmunityBio's strategy, stimulating natural killer cells, cytotoxic T cells, and memory T cells. These advancements help patients combat various cancers and diseases, with the majority of revenue coming from U.S. sales of Anktiva, particularly for bladder cancer cases unresponsive to Bacille Calmette-Guérin treatment. IBRX's market capitalization stands at approximately $9.57 billion, with a trading volume of 73.67 million shares. The stock has fluctuated between $9.59 and $11 today, with a 52-week high of $11 and a low of $1.83. These figures reflect the company's growth potential and the market's confidence in its innovative cancer treatment solutions.

Tredu Team | Insights

Dream Industrial Real Estate Investment Trust's (OTC:DREUF) Performance and Outlook

Dream Industrial Real Estate Investment Trust's (OTC:DREUF) Performance and Outlook

Dream Industrial Real Estate Investment Trust (OTC:DREUF) is a prominent player in the real estate sector, focusing on industrial properties. The company is known for its strategic investments and management of industrial real estate assets. It competes with other real estate investment trusts (REITs) in the market, striving to deliver value to its investors through consistent growth and performance. On February 23, 2026, RBC Capital updated its rating for DREUF to "Outperform," indicating confidence in the stock's future performance. At the time, the stock was priced at $9.80. RBC Capital also raised the price target for Dream Industrial REIT from C$14 to C$15, suggesting potential for further appreciation. Dream Industrial REIT has reported strong financial results for the fourth quarter and the full year ending December 31, 2025. The company achieved a 5% growth in Funds From Operations (FFO) per unit, showcasing its ability to generate cash flow and maintain financial health. This performance supports RBC Capital's positive outlook on the stock. The current price of DREUF is $9.80, reflecting a change of $0.13, which is an increase of approximately 1.34%. The stock has shown stability, with a daily fluctuation between $9.80 and $9.81. Over the past year, DREUF has reached a high of $9.96 and a low of $6.68, indicating a recovery and growth trend. Dream Industrial REIT's market capitalization is approximately $2.8 billion, highlighting its significant presence in the market. The stock is traded on the OTC exchange, with a current volume of 300 shares.

Tredu Team | Insights

Lincoln Educational Services Corporation's Strong Financial Performance

Lincoln Educational Services Corporation's Strong Financial Performance

Earnings Per Share (EPS) of $0.50, surpassing the estimated $0.42, marking a positive surprise of 19.05%. Revenue reached approximately $142.9 million, exceeding the anticipated $128.5 million. Consistent ability to surpass earnings expectations, showcasing strong operational capabilities and strategic execution. Lincoln Educational Services Corporation, listed on NASDAQ as LINC, has demonstrated strong financial performance in its recent earnings report. On February 23, 2026, LINC reported earnings per share (EPS) of $0.50, surpassing the estimated $0.42. This marks a positive surprise of 19.05%, as highlighted by Zacks. The company also achieved a revenue of approximately $142.9 million, exceeding the anticipated $128.5 million. The company's consistent ability to surpass earnings expectations is noteworthy. In the previous quarter, LINC delivered earnings of $0.20 per share against an anticipated $0.12, resulting in a 66.67% surprise. Over the past four quarters, Lincoln Educational Services has consistently outperformed consensus EPS estimates, showcasing its strong operational capabilities and strategic execution. LINC's revenue growth is equally impressive. For the quarter ending December 2025, the company achieved revenues of $142.9 million, exceeding the Zacks Consensus Estimate by 7.74%. This figure also represents a significant increase from the $119.37 million in revenues from the same period the previous year. The company's ability to consistently outperform consensus revenue estimates highlights its robust business model and market position. Financial metrics further illustrate LINC's market standing. The company has a price-to-earnings (P/E) ratio of approximately 72, indicating investor confidence in its earnings potential. The price-to-sales ratio stands at about 2.1, while the enterprise value to sales ratio is approximately 2.47. These figures reflect the company's valuation in relation to its sales and earnings. Despite these positive indicators, LINC faces some financial challenges. The enterprise value to operating cash flow ratio is around 26.45, suggesting a need for efficient cash flow management. Additionally, the current ratio is about 0.81, indicating potential challenges in covering short-term liabilities with short-term assets. However, the company's debt-to-equity ratio of approximately 1.05 shows a balanced approach to financing its assets.

Connect with Verified Trading
Educators for Tailored Mentorship
Across All Trading Styles

ADVANCED SEARCH

108 results

Top Brokers

Secure Your Trading Journey with the Right Broker

Advertisement for tredu.com - trading platform

Proud Media Partners of

Cyprus Fintech SummitMoney ExpoGlobal AI Show Abu DhabiGlobal Games ShowForex Expo DubaiGlobal Blockchain ShowEuropean Blockchain ConventionCyprus Fintech SummitMoney ExpoGlobal Games ShowFinancial Innovation ForumGlobal AI Show Abu DhabiForex Expo DubaiGlobal Games ShowCyprus Fintech SummitMoney ExpoGlobal Blockchain ShowEuropean Blockchain ConventionGlobal AI Show Abu DhabiFinancial Innovation ForumForex Expo DubaiGlobal Blockchain ShowCyprus Fintech SummitMoney ExpoEuropean Blockchain ConventionGlobal AI Show Abu DhabiFinancial Innovation ForumCyprus Fintech SummitMoney ExpoGlobal AI Show Abu DhabiGlobal Games ShowForex Expo DubaiGlobal Blockchain ShowEuropean Blockchain ConventionCyprus Fintech SummitMoney ExpoGlobal Games ShowFinancial Innovation ForumGlobal AI Show Abu DhabiForex Expo DubaiGlobal Games ShowCyprus Fintech SummitMoney ExpoGlobal Blockchain ShowEuropean Blockchain ConventionGlobal AI Show Abu DhabiFinancial Innovation ForumForex Expo DubaiGlobal Blockchain ShowCyprus Fintech SummitMoney ExpoEuropean Blockchain ConventionGlobal AI Show Abu DhabiFinancial Innovation Forum